Manifold Partners’s Arcturus Therapeutics ARCT Stock Holding History

Manifold Partners’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-371	Closed	-$47K	–	64
2013 Q4	$47K	Buy	371 +100	+37%	+$12.6K	0.03%	87
2013 Q3	$35K	Buy	+271	New	+$24.1K	0.02%	87

Other funds holding ARCT

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Arrowgrass Capital Partners (US) Dover, Delaware $41.7M AUM 20.87% 1-Year Est. Return

Trellus Management Company Delray Beach, Florida $51.7M AUM 4.5% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return